Biocon Ltd, an indian biotech company are developingan oral insulin.1N-105 is a novel analog of insulin.Phase 1 studies show promising results.A potential competitor for aop.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor